EARNEST Partners’s Repligen RGEN Stock Holding History

EARNEST Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-38	Closed	-$6.04K	–	922
2023 Q3	$6.04K	Hold	38	–	–	﹤0.01%	747
2023 Q2	$5.38K	Hold	38	–	–	﹤0.01%	784
2023 Q1	$6.4K	Hold	38	–	–	﹤0.01%	721
2022 Q4	$6.43K	Hold	38	–	–	﹤0.01%	722
2022 Q3	$7K	Hold	38	–	–	﹤0.01%	688
2022 Q2	$6K	Hold	38	–	–	﹤0.01%	745
2022 Q1	$7K	Hold	38	–	–	﹤0.01%	752
2021 Q4	$10K	Hold	38	–	–	﹤0.01%	679
2021 Q3	$11K	Hold	38	–	–	﹤0.01%	639
2021 Q2	$8K	Hold	38	–	–	﹤0.01%	727
2021 Q1	$7K	Hold	38	–	–	﹤0.01%	744
2020 Q4	$7K	Hold	38	–	–	﹤0.01%	726
2020 Q3	$6K	Buy	+38	New	+$5.43K	﹤0.01%	715

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EARNEST Partners's RGEN Position: Q4 2023 in Review

EARNEST Partners sold out of Repligen (RGEN) in Q4 2023, closing a stake of 38 shares — an estimated $6.04K sold.

EARNEST Partners first reported a position in RGEN in Q3 2020 and held it in 13 quarters. The position peaked at $11K in Q3 2021. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

EARNEST Partners reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 38 Repligen shares in Q4 2023, an estimated $6.04K.
EARNEST Partners first reported a position in Repligen in Q3 2020 and held it in 13 quarters.
EARNEST Partners's Repligen position peaked at $11K in Q3 2021.
466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.